Introduction: The possibility of successful smoking cessation is increased by early initiation. Therefore, promoting smoking cessation at early age (especially among 14-35-year-olds) has a key role in reducing tobacco use prevalence. Facebook is one of the most popular websites among adolescents and young adults which can be used for age-specific smoking cessation support.
Aim: Our research seeks to reveal the effects of a Facebook page on smoking habits, smoking cessation knowledge and attitudes among 14-35-year-olds.
Method: An online survey was conducted among the 3278 followers of the author's Facebook page. The questionnaire was completed by 332 people among 14-35-year-olds. We analysed demographic data, smoking habits, the usage frequency and duration of the Facebook page as well as changes in smoking habits, smoking cessation knowledge and attitudes.
Results: The average age was 22.57 ± 5.08 years. The examined population consisted of 65% currently smokers, 12% former smokers and 23% non-smokers. Significantly more people reported a positive change in their smoking habits and smoking cessation attitudes among smokers who used the Facebook page more frequently and with longer duration (p<0.05). The habit and attitude changes were significantly higher among smokers who plan to quit smoking (p<0.01). Nevertheless, we also observed attitude changes between 12-25% among smokers who did not plan to quit. Among non-smokers, the positive attitude changes were significantly higher in the low-educated population who live in villages (p<0.01).
Conclusion: This Facebook page had a positive effect on smoking habits, smoking cessation knowledge and attitudes among 14-35-year-olds. The contents of the Facebook page could be used to prevent smoking and support smoking cessation among 14-35-year-olds. Orv Hetil. 2019; 160(6): 220-227.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1556/650.2019.31314 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genome-wide association study of varenicline-aided smoking cessation.
Nicotine Tob Res
January 2025
Department of Population Health Sciences, University of Leicester, Leicester, UK.
Introduction: Varenicline is an α4β2 nicotinic acetylcholine receptor partial agonist with the highest therapeutic efficacy of any pharmacological smoking cessation aid and a 12-month cessation rate of 26%. Genetic variation may be associated with varenicline response, but to date no genome-wide association studies of varenicline response have been published.
Methods: In this study, we investigated the genetic contribution to varenicline effectiveness using two electronic health record-derived phenotypes.
A Study on Adolescent Smoking Prevention and Cessation Policies: Based on the Propensity Score Matching-Difference-in-Differences Method.
Healthcare (Basel)
December 2024
Department of Health Administration, Gyeonggi University of Science and Technology, Gyeonggi 15073, Republic of Korea.
: Adolescent smoking can lead to various health problems including atherosclerosis and cardiovascular disease, making it more difficult to quit smoking during adulthood. This study aims to evaluate the effect of the ordinance by assessing adolescents' smoking cessation behaviors and environmental conditions, according to the "Ordinance for the Prevention of Child and Adolescent Smoking and Support for Smoking Cessation", which was enacted in 2019 in Gwangju City, South Korea, for the first time in the country. : The data for the analysis were obtained from the 2018 and 2021 Korea Youth Risk Behavior Survey.
View Article and Find Full Text PDFCoping and Social Support in Relation to Minority Stress and Cigarette Smoking Among Lesbian, Gay, and Bisexual Veterans.
Ann LGBTQ Public Popul Health
December 2024
Department of Health Systems and Population Health, University of Washington, School of Public Health, Seattle, WA, USA.
The intersection between a minoritized sexual orientation identity and a U.S. military Veteran status places lesbian, gay, and bisexual (LGB) Veterans at increased risk for cigarette smoking.
View Article and Find Full Text PDFState of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs.
JTO Clin Res Rep
January 2025
Icahn School of Medicine at Mount Sinai, New York, New York.
Lung cancer remains a leading cause of cancer-related mortality globally and presents significant challenges in Egypt. In 2023, the first annual meeting of the Thoracic Oncology Multidisciplinary Faculty, organized by the Egyptian Cancer Research Network and the Egyptian Society of Respiratory Neoplasms, was held in Cairo, Egypt. The meeting aimed to address gaps in lung cancer management across Egypt and the broader Middle East and North Africa region.
View Article and Find Full Text PDFIntroduction: The impact of e-cigarette flavoring on e-cigarette uptake and switching to e-cigarettes among adults who smoke is critical to e-cigarette regulation in the United Sates. The purpose of this secondary analysis was to assess the impact of e-cigarette flavoring choice on e-cigarette uptake and changes in cigarette smoking in a large nationwide trial of e-cigarette provision in the United States.
Methods: A free four-week supply of e-cigarettes was provided with minimal instructions to use to adults who smoke (N = 427).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!